| Title |
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
|
|---|---|
| Published in |
JAMA Oncology, May 2020
|
| DOI | 10.1001/jamaoncol.2020.0147 |
| Pubmed ID | |
| Authors |
Ryan Phillips, William Yue Shi, Matthew Deek, Noura Radwan, Su Jin Lim, Emmanuel S. Antonarakis, Steven P. Rowe, Ashley E. Ross, Michael A. Gorin, Curtiland Deville, Stephen C. Greco, Hailun Wang, Samuel R. Denmeade, Channing J. Paller, Shirl Dipasquale, Theodore L. DeWeese, Daniel Y. Song, Hao Wang, Michael A. Carducci, Kenneth J. Pienta, Martin G. Pomper, Adam P. Dicker, Mario A. Eisenberger, Ash A. Alizadeh, Maximilian Diehn, Phuoc T. Tran |
X Demographics
The data shown below were collected from the profiles of 233 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 58 | 25% |
| Spain | 14 | 6% |
| France | 11 | 5% |
| Brazil | 11 | 5% |
| Mexico | 7 | 3% |
| Germany | 7 | 3% |
| United Kingdom | 6 | 3% |
| Australia | 6 | 3% |
| Belgium | 5 | 2% |
| Other | 36 | 15% |
| Unknown | 72 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 133 | 57% |
| Scientists | 59 | 25% |
| Practitioners (doctors, other healthcare professionals) | 37 | 16% |
| Science communicators (journalists, bloggers, editors) | 3 | 1% |
| Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 429 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 429 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 57 | 13% |
| Other | 47 | 11% |
| Student > Ph. D. Student | 30 | 7% |
| Student > Bachelor | 30 | 7% |
| Student > Doctoral Student | 27 | 6% |
| Other | 105 | 24% |
| Unknown | 133 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 173 | 40% |
| Biochemistry, Genetics and Molecular Biology | 15 | 3% |
| Unspecified | 13 | 3% |
| Engineering | 13 | 3% |
| Nursing and Health Professions | 10 | 2% |
| Other | 44 | 10% |
| Unknown | 161 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 282. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2023.
All research outputs
#127,444
of 25,837,817 outputs
Outputs from JAMA Oncology
#225
of 3,345 outputs
Outputs of similar age
#4,631
of 423,015 outputs
Outputs of similar age from JAMA Oncology
#3
of 96 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,345 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 84.3. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,015 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.